{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:30:13Z","timestamp":1786120213311,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10,1]]},"DOI":"10.1097\/qai.0b013e31822b8bf8","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T15:42:26Z","timestamp":1317742946000},"page":"e40-e43","source":"Crossref","is-referenced-by-count":25,"title":["Combined Oral Contraceptives and Antiretroviral PK\/PD in Malawian Women: Pharmacokinetics and Pharmacodynamics of a Combined Oral Contraceptive and a Generic Combined Formulation Antiretroviral in Malawi"],"prefix":"10.1097","volume":"58","author":[{"given":"Gretchen S","family":"Stuart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Moses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Phiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiza","family":"Kumwenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nkhafwire","family":"Mkandawire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Chintedze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Malunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Hosseinipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron S","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Z","family":"Stanczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela D.M","family":"Kashuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-23-20210131","doi-asserted-by":"crossref","first-page":"ii49","DOI":"10.1136\/sti.2008.030049","article-title":"Contraception to prevent HIV-positive births: current contribution and potential cost savings in PEPFAR countries.","volume":"84","author":"Reynolds","year":"2008","journal-title":"Sex Transm Infect"},{"issue":"2","key":"R9-23-20210131","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3851\/IMP1725","article-title":"The effect of efavirenz on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy HIV-negative women.","volume":"16","author":"Sevinsky","year":"2011","journal-title":"Antivir Ther"},{"key":"R13-23-20210131","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2008.02.020","article-title":"Oral contraceptives and individual variability of circulating levels of ethinyl estradiol and progestins.","volume":"78","author":"Goldzieher","year":"2008","journal-title":"Contraception"},{"key":"R16-23-20210131","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00042560-200204150-00007","article-title":"Pharmacokinetic interaction between nevirapine and ethinyl estradiol\/norethindrone when administered concurrently to HIV-infected women.","volume":"29","author":"Mildvan","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R17-23-20210131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/QAD.0b013e3280117ca0","article-title":"Pharmacokinetic comparison of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian adults.","volume":"21","author":"Hosseinipour","year":"2007","journal-title":"AIDS"},{"key":"R18-23-20210131","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1570-0232(03)00224-1","article-title":"Simultaneous determination of six HIV nucleoside analogue reverse transcriptase inhibitors and nevirapine by liquid chromatography with ultraviolet absorbance detection.","volume":"791","author":"Rezk","year":"2003","journal-title":"J Chromatog B Analyt Techno Biomed Life Sci"},{"key":"R19-23-20210131","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0010-7824(75)90088-8","article-title":"Radioimmunoassay of serum d-norgestrel in women following oral and intravaginal administration.","volume":"12","author":"Stanczyk","year":"1975","journal-title":"Contraception"},{"key":"R20-23-20210131","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/S0002-9378(11)90772-8","article-title":"Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.","volume":"168","author":"Price","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"R22-23-20210131","first-page":"29","article-title":"Ovulation and follicular development associated with three low-dose oral contraceptives: a randomized controlled trial.","volume":"83","author":"Grimes","year":"1994","journal-title":"Obstet Gynecol"},{"key":"R23-23-20210131","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/13625180701829952","article-title":"Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives.","volume":"13","author":"El-Ibiary","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R24-23-20210131","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1086\/507097","article-title":"Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration.","volume":"43","author":"Haas","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R27-23-20210131","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S0021932005026647","article-title":"Skewed contraceptive method mix: why it happens, why it matters.","volume":"38","author":"Sullivan","year":"2006","journal-title":"J Biosoc Sci"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201110010-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:27:02Z","timestamp":1786048022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201110010-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,1]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31822b8bf8","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10,1]]}}}